Size-specific dose estimates for adult patients at CT of the torso.

Purpose: To determine relationships among patient size, scanner radiation output, and size-specific dose estimates (SSDEs) for adults who underwent computed tomography (CT) of the torso.

Materials And Methods: Informed consent was waived for this institutional review board-approved study of existing data from 545 adult patients (322 men, 223 women) who underwent clinically indicated CT of the torso between April 1, 2007, and May 13, 2007. Automatic exposure control was used to adjust scanner output for each patient according to the measured CT attenuation.

Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex.

Our laboratory has recently demonstrated altered expression of phosphodiesterase (PDE) 4A and 4B in subjects with autism, bipolar disorder, and schizophrenia, suggesting disrupted cAMP signaling in these diagnostic groups. In the current study, we measured expression of PDEs in rat frontal cortex (FC) following chronic treatment with clozapine, fluoxetine, haloperidol, lithium, olanzapine, valproic acid (VPA), or sterile saline for 21 days. Western blotting experiments showed decreased expression of PDE4A subtypes in FC following treatment with clozapine, haloperidol, lithium, and VPA.

Dual-source computed tomographic temporal resolution provides higher image quality than 64-detector temporal resolution at low heart rates.

Objective: To compare coronary image quality at temporal resolutions associated with dual-source computed tomography (DSCT; 83 milliseconds) and 64-detector row scanning (165 milliseconds).

Methods: In 30 patients with a heart rate of less than 70 beats per minute, DSCT coronary angiograms were reconstructed at 83- and 165-millisecond temporal resolutions over different cardiac phases. A blinded observer graded coronary quality.

Optimal image reconstruction phase at low and high heart rates in dual-source CT coronary angiography.

The purpose of this study was to determine the cardiac phase having the highest coronary sharpness for low and high heart rate patients scanned with dual source CT (DSCT) and to compare coronary image sharpness over different cardiac phases. DSCT coronary CT scans for 30 low heart rate (< or =70 beats per minute- bpm) and 30 high heart rate (>70 bpm) patients were reconstructed into different cardiac phases, starting at 30% and increasing at 5% increments until 70%. A blinded observer graded image sharpness per coronary segment, from which sharpness scores were produced for the right (RCA), left main (LM), left anterior descending (LAD), and circumflex (Cx) coronary arteries.

Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats.

Astrocytic markers glial fibrillary acidic protein (GFAP) and connexin 43 (CX43) are known to have altered expression in brains of subjects with psychiatric disorders including autism and major depression. The current study investigated whether GFAP and CX43 expressions are affected by several commonly used psychotropic medications (clozapine, fluoxetine, haloperidol, lithium, olanzapine, and valproic acid). Using SDS-PAGE and western blotting technique, we observed that CX43 protein expression in prefrontal cortex was significantly increased following chronic treatment with fluoxetine and clozapine, while it was significantly decreased by haloperidol and lithium.

Expression of phosphodiesterase 4 is altered in the brains of subjects with autism.

The cyclic adenosine monophosphate-specific phosphodiesterase-4 (PDE4) gene family is the target of several potential therapeutic inhibitors and the PDE4B gene has been associated with schizophrenia and depression. Little, however, is known of any connection between this gene family and autism, with limited effective treatment being available for autism. We measured the expression of PDE4A and PDE4B by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting in Brodmann's area 40 (BA40, parietal cortex), BA9 (superior frontal cortex), and cerebellum from subjects with autism and matched controls.

Radiation exposure and pregnancy: when should we be concerned?

The potential biological effects of in utero radiation exposure of a developing fetus include prenatal death, intrauterine growth restriction, small head size, mental retardation, organ malformation, and childhood cancer. The risk of each effect depends on the gestational age at the time of exposure, fetal cellular repair mechanisms, and the absorbed radiation dose level. A comparison between the dose levels associated with each of these risks and the estimated fetal doses from typical radiologic examinations lends support to the conclusion that fetal risks are minimal and, therefore, that radiologic and nuclear medicine examinations that may provide significant diagnostic information should not be withheld from pregnant women.